Clinical Data Management
Database design, data cleaning, CDISC SDTM mapping, and database lock — delivered with rigorous quality controls and full audit traceability.
Clinical data management and analytics services trusted by global pharmaceutical leaders to accelerate regulatory submissions and unlock trial insights.
End-to-end clinical data services and proprietary analytics technology, delivered by 300+ specialists across six core practice areas.
Database design, data cleaning, CDISC SDTM mapping, and database lock — delivered with rigorous quality controls and full audit traceability.
SAP authoring, SAS and R programming, TFL production, integrated summaries of safety and efficacy for global regulatory submissions.
Clinical Study Reports, Investigator Brochures, and submission-ready dossiers for NDA, BLA and MAA filings across major markets.
Safety database operations, signal detection, SUSAR reporting, and aggregate safety reporting (PBRER, DSUR) at global scale.
CDISC compliance, define.xml generation, ADaM datasets, and FDA/EMA submission readiness with eCTD-compliant deliverables.
Our proprietary clinical analytics platform — real-time data quality monitoring, automated CDISC mapping, and multi-study portfolio insight.
A validated, 21 CFR Part 11-compliant analytics platform built by clinicians and statisticians for clinicians and statisticians. Plug it into your existing EDC or use it standalone.
A decade of partnership with the world's most demanding clinical programmes — built on three uncompromising commitments.
ICH E6(R2) compliant, ISO 9001:2015 certified, with full audit-readiness at all times. Every dataset, every deliverable, fully traceable and inspection-ready.
Regulatory expertise across the FDA, EMA, PMDA and 35+ national authorities. Multilingual operations supporting trials in over 20 countries.
300+ specialists including PhDs, biostatisticians, and certified data scientists — combining methodological depth with deep therapeutic-area expertise.
Decades of combined experience across pharma, biotech and the regulatory sciences.
Former VP of Clinical Operations at a top-10 pharma. PhD in Biostatistics, University of Cambridge.
Twenty years authoring SAPs for global Phase II/III oncology trials. PhD in Statistics, Stanford.
Built strategic alliances with five top-20 pharma sponsors. MBA, INSEAD; MSc Pharmacology.
Ex-MHRA inspector. Specialist in 21 CFR Part 11, ICH E6(R2) and EMA-equivalent quality systems.
Nexagen's biostatistics team delivered our Phase III TFLs three weeks ahead of schedule. Their CDISC expertise and NexaCore™ platform gave us real-time visibility we'd never had before.— VP Clinical Operations, Top-10 Global Pharmaceutical Company
Whether you're scoping a new programme or evaluating partners, our team will respond within one business day.
200 Aldersgate Street
London, EC1A 4HD
United Kingdom